The Military Health System: Minimizing Disparities in Breast Cancer Treatment , November 8 , 2023
The Military Health System: Minimizing Disparities in Breast Cancer Treatment , November 8 , 2023
From the document: “Breast cancer is the most common cancer diagnosed among women in the United States, affecting one in eight women in their lifetime. The American Cancer Society projects that over 330,000 women will receive a new breast cancer diagnosis in 2022 with over 43,000 women estimated to die as a result of their diagnosis.1 Rapid identification and initiation of treatment following a diagnosis of breast cancer are critical to improving outcomes, as delays in breast cancer treatment can have a significant effect on patient mortality. The treatment of breast cancer can be unimodal or multimodal and can involve surgery, radiation, and/or chemotherapy, including immunotherapy and/or hormonal therapy. Although no consensus guidelines exist, the suggested intervals from diagnosis to treatment initiation are less than 90 days for surgery or less than 120 days for chemotherapy.3 It is further recommended that radiation therapy be initiated within 365 days of receiving chemotherapy when administered in sequence with chemotherapy.”
Authors - Liggett, Jedson R., Norris, Emily A., Rush, Toni M., Sicignano, Nicholas M., Oxner, ChristopherSubjects
Authors
Format
Related Resources
